ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. (Q46043714)
Jump to navigation
Jump to search
scientific article published in May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. |
scientific article published in May 2009 |
Statements
ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis (English)
Cory M Hogaboam
Vanessa Martins
Francisco A Farias-Filho
Raphael Molinaro
Rafael L Simões
Tatiana P T Ferreira
Patrícia M R e Silva
Steven L Kunkel
Iolanda M Fierro
Claudio Canetti
Claudia F Benjamim